IBDEI0TU ; ; 01-FEB-2022
;;3.0;IB ENCOUNTER FORM IMP/EXP;;FEB 01, 2022
Q:'DIFQR(358.3) F I=1:2 S X=$T(Q+I) Q:X="" S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,999) S:$A(Y)=61 Y=$E(Y,2,999) X NO E S @X=Y
Q Q
;;^UTILITY(U,$J,358.3,13426,2)
;;=^5006142
;;^UTILITY(U,$J,358.3,13427,0)
;;=M31.6^^51^636^19
;;^UTILITY(U,$J,358.3,13427,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,13427,1,3,0)
;;=3^Giant Cell Arteritis,Other
;;^UTILITY(U,$J,358.3,13427,1,4,0)
;;=4^M31.6
;;^UTILITY(U,$J,358.3,13427,2)
;;=^5011748
;;^UTILITY(U,$J,358.3,13428,0)
;;=H53.47^^51^636^26
;;^UTILITY(U,$J,358.3,13428,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,13428,1,3,0)
;;=3^Heteronymous Bilateral Field Defects
;;^UTILITY(U,$J,358.3,13428,1,4,0)
;;=4^H53.47
;;^UTILITY(U,$J,358.3,13428,2)
;;=^268847
;;^UTILITY(U,$J,358.3,13429,0)
;;=H53.462^^51^636^25
;;^UTILITY(U,$J,358.3,13429,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,13429,1,3,0)
;;=3^Homonymous Bilateral Field Defects,Left Side
;;^UTILITY(U,$J,358.3,13429,1,4,0)
;;=4^H53.462
;;^UTILITY(U,$J,358.3,13429,2)
;;=^5006342
;;^UTILITY(U,$J,358.3,13430,0)
;;=H53.461^^51^636^24
;;^UTILITY(U,$J,358.3,13430,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,13430,1,3,0)
;;=3^Homonymous Bilateral Field Defects,Right Side
;;^UTILITY(U,$J,358.3,13430,1,4,0)
;;=4^H53.461
;;^UTILITY(U,$J,358.3,13430,2)
;;=^5006341
;;^UTILITY(U,$J,358.3,13431,0)
;;=H47.013^^51^636^9
;;^UTILITY(U,$J,358.3,13431,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,13431,1,3,0)
;;=3^Ischemic Optic Neuropathy,Bilateral
;;^UTILITY(U,$J,358.3,13431,1,4,0)
;;=4^H47.013
;;^UTILITY(U,$J,358.3,13431,2)
;;=^5006107
;;^UTILITY(U,$J,358.3,13432,0)
;;=H47.011^^51^636^7
;;^UTILITY(U,$J,358.3,13432,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,13432,1,3,0)
;;=3^Ischemic Optic Neuropathy,Right Eye
;;^UTILITY(U,$J,358.3,13432,1,4,0)
;;=4^H47.011
;;^UTILITY(U,$J,358.3,13432,2)
;;=^5006105
;;^UTILITY(U,$J,358.3,13433,0)
;;=H47.012^^51^636^8
;;^UTILITY(U,$J,358.3,13433,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,13433,1,3,0)
;;=3^Ischemic Optic Neuropathy,Left Eye
;;^UTILITY(U,$J,358.3,13433,1,4,0)
;;=4^H47.012
;;^UTILITY(U,$J,358.3,13433,2)
;;=^5006106
;;^UTILITY(U,$J,358.3,13434,0)
;;=H47.233^^51^636^6
;;^UTILITY(U,$J,358.3,13434,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,13434,1,3,0)
;;=3^Optic Atrophy,Glaucomatous,Bilateral
;;^UTILITY(U,$J,358.3,13434,1,4,0)
;;=4^H47.233
;;^UTILITY(U,$J,358.3,13434,2)
;;=^5006133
;;^UTILITY(U,$J,358.3,13435,0)
;;=H47.231^^51^636^4
;;^UTILITY(U,$J,358.3,13435,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,13435,1,3,0)
;;=3^Optic Atrophy,Glaucomatous,Right Eye
;;^UTILITY(U,$J,358.3,13435,1,4,0)
;;=4^H47.231
;;^UTILITY(U,$J,358.3,13435,2)
;;=^5006131
;;^UTILITY(U,$J,358.3,13436,0)
;;=H47.232^^51^636^5
;;^UTILITY(U,$J,358.3,13436,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,13436,1,3,0)
;;=3^Optic Atrophy,Glaucomatous,Left Eye
;;^UTILITY(U,$J,358.3,13436,1,4,0)
;;=4^H47.232
;;^UTILITY(U,$J,358.3,13436,2)
;;=^5006132
;;^UTILITY(U,$J,358.3,13437,0)
;;=H46.9^^51^636^19
;;^UTILITY(U,$J,358.3,13437,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,13437,1,3,0)
;;=3^Optic Neuritis,Unspec
;;^UTILITY(U,$J,358.3,13437,1,4,0)
;;=4^H46.9
;;^UTILITY(U,$J,358.3,13437,2)
;;=^5006104
;;^UTILITY(U,$J,358.3,13438,0)
;;=H46.03^^51^636^15
;;^UTILITY(U,$J,358.3,13438,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,13438,1,3,0)
;;=3^Optic Papillitis,Bilateral
;;^UTILITY(U,$J,358.3,13438,1,4,0)
;;=4^H46.03
;;^UTILITY(U,$J,358.3,13438,2)
;;=^5006099
--- Routine Detail --- with STRUCTURED ROUTINE LISTING ---[H[J[2J[HIBDEI0TU 3753 printed Sep 15, 2024@21:19:53 Page 2
IBDEI0TU ; ; 01-FEB-2022
+1 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;FEB 01, 2022
+2 if 'DIFQR(358.3)
QUIT
FOR I=1:2
SET X=$TEXT(Q+I)
if X=""
QUIT
SET Y=$EXTRACT($TEXT(Q+I+1),4,999)
SET X=$EXTRACT(X,4,999)
if $ASCII(Y)=126
SET I=I+1
SET Y=$EXTRACT(Y,2,999)_$EXTRACT($TEXT(Q+I+1),5,999)
if $ASCII(Y)=61
SET Y=$EXTRACT(Y,2,999)
XECUTE NO
IF '$TEST
SET @X=Y
Q QUIT
+1 ;;^UTILITY(U,$J,358.3,13426,2)
+2 ;;=^5006142
+3 ;;^UTILITY(U,$J,358.3,13427,0)
+4 ;;=M31.6^^51^636^19
+5 ;;^UTILITY(U,$J,358.3,13427,1,0)
+6 ;;=^358.31IA^4^2
+7 ;;^UTILITY(U,$J,358.3,13427,1,3,0)
+8 ;;=3^Giant Cell Arteritis,Other
+9 ;;^UTILITY(U,$J,358.3,13427,1,4,0)
+10 ;;=4^M31.6
+11 ;;^UTILITY(U,$J,358.3,13427,2)
+12 ;;=^5011748
+13 ;;^UTILITY(U,$J,358.3,13428,0)
+14 ;;=H53.47^^51^636^26
+15 ;;^UTILITY(U,$J,358.3,13428,1,0)
+16 ;;=^358.31IA^4^2
+17 ;;^UTILITY(U,$J,358.3,13428,1,3,0)
+18 ;;=3^Heteronymous Bilateral Field Defects
+19 ;;^UTILITY(U,$J,358.3,13428,1,4,0)
+20 ;;=4^H53.47
+21 ;;^UTILITY(U,$J,358.3,13428,2)
+22 ;;=^268847
+23 ;;^UTILITY(U,$J,358.3,13429,0)
+24 ;;=H53.462^^51^636^25
+25 ;;^UTILITY(U,$J,358.3,13429,1,0)
+26 ;;=^358.31IA^4^2
+27 ;;^UTILITY(U,$J,358.3,13429,1,3,0)
+28 ;;=3^Homonymous Bilateral Field Defects,Left Side
+29 ;;^UTILITY(U,$J,358.3,13429,1,4,0)
+30 ;;=4^H53.462
+31 ;;^UTILITY(U,$J,358.3,13429,2)
+32 ;;=^5006342
+33 ;;^UTILITY(U,$J,358.3,13430,0)
+34 ;;=H53.461^^51^636^24
+35 ;;^UTILITY(U,$J,358.3,13430,1,0)
+36 ;;=^358.31IA^4^2
+37 ;;^UTILITY(U,$J,358.3,13430,1,3,0)
+38 ;;=3^Homonymous Bilateral Field Defects,Right Side
+39 ;;^UTILITY(U,$J,358.3,13430,1,4,0)
+40 ;;=4^H53.461
+41 ;;^UTILITY(U,$J,358.3,13430,2)
+42 ;;=^5006341
+43 ;;^UTILITY(U,$J,358.3,13431,0)
+44 ;;=H47.013^^51^636^9
+45 ;;^UTILITY(U,$J,358.3,13431,1,0)
+46 ;;=^358.31IA^4^2
+47 ;;^UTILITY(U,$J,358.3,13431,1,3,0)
+48 ;;=3^Ischemic Optic Neuropathy,Bilateral
+49 ;;^UTILITY(U,$J,358.3,13431,1,4,0)
+50 ;;=4^H47.013
+51 ;;^UTILITY(U,$J,358.3,13431,2)
+52 ;;=^5006107
+53 ;;^UTILITY(U,$J,358.3,13432,0)
+54 ;;=H47.011^^51^636^7
+55 ;;^UTILITY(U,$J,358.3,13432,1,0)
+56 ;;=^358.31IA^4^2
+57 ;;^UTILITY(U,$J,358.3,13432,1,3,0)
+58 ;;=3^Ischemic Optic Neuropathy,Right Eye
+59 ;;^UTILITY(U,$J,358.3,13432,1,4,0)
+60 ;;=4^H47.011
+61 ;;^UTILITY(U,$J,358.3,13432,2)
+62 ;;=^5006105
+63 ;;^UTILITY(U,$J,358.3,13433,0)
+64 ;;=H47.012^^51^636^8
+65 ;;^UTILITY(U,$J,358.3,13433,1,0)
+66 ;;=^358.31IA^4^2
+67 ;;^UTILITY(U,$J,358.3,13433,1,3,0)
+68 ;;=3^Ischemic Optic Neuropathy,Left Eye
+69 ;;^UTILITY(U,$J,358.3,13433,1,4,0)
+70 ;;=4^H47.012
+71 ;;^UTILITY(U,$J,358.3,13433,2)
+72 ;;=^5006106
+73 ;;^UTILITY(U,$J,358.3,13434,0)
+74 ;;=H47.233^^51^636^6
+75 ;;^UTILITY(U,$J,358.3,13434,1,0)
+76 ;;=^358.31IA^4^2
+77 ;;^UTILITY(U,$J,358.3,13434,1,3,0)
+78 ;;=3^Optic Atrophy,Glaucomatous,Bilateral
+79 ;;^UTILITY(U,$J,358.3,13434,1,4,0)
+80 ;;=4^H47.233
+81 ;;^UTILITY(U,$J,358.3,13434,2)
+82 ;;=^5006133
+83 ;;^UTILITY(U,$J,358.3,13435,0)
+84 ;;=H47.231^^51^636^4
+85 ;;^UTILITY(U,$J,358.3,13435,1,0)
+86 ;;=^358.31IA^4^2
+87 ;;^UTILITY(U,$J,358.3,13435,1,3,0)
+88 ;;=3^Optic Atrophy,Glaucomatous,Right Eye
+89 ;;^UTILITY(U,$J,358.3,13435,1,4,0)
+90 ;;=4^H47.231
+91 ;;^UTILITY(U,$J,358.3,13435,2)
+92 ;;=^5006131
+93 ;;^UTILITY(U,$J,358.3,13436,0)
+94 ;;=H47.232^^51^636^5
+95 ;;^UTILITY(U,$J,358.3,13436,1,0)
+96 ;;=^358.31IA^4^2
+97 ;;^UTILITY(U,$J,358.3,13436,1,3,0)
+98 ;;=3^Optic Atrophy,Glaucomatous,Left Eye
+99 ;;^UTILITY(U,$J,358.3,13436,1,4,0)
+100 ;;=4^H47.232
+101 ;;^UTILITY(U,$J,358.3,13436,2)
+102 ;;=^5006132
+103 ;;^UTILITY(U,$J,358.3,13437,0)
+104 ;;=H46.9^^51^636^19
+105 ;;^UTILITY(U,$J,358.3,13437,1,0)
+106 ;;=^358.31IA^4^2
+107 ;;^UTILITY(U,$J,358.3,13437,1,3,0)
+108 ;;=3^Optic Neuritis,Unspec
+109 ;;^UTILITY(U,$J,358.3,13437,1,4,0)
+110 ;;=4^H46.9
+111 ;;^UTILITY(U,$J,358.3,13437,2)
+112 ;;=^5006104
+113 ;;^UTILITY(U,$J,358.3,13438,0)
+114 ;;=H46.03^^51^636^15
+115 ;;^UTILITY(U,$J,358.3,13438,1,0)
+116 ;;=^358.31IA^4^2
+117 ;;^UTILITY(U,$J,358.3,13438,1,3,0)
+118 ;;=3^Optic Papillitis,Bilateral
+119 ;;^UTILITY(U,$J,358.3,13438,1,4,0)
+120 ;;=4^H46.03
+121 ;;^UTILITY(U,$J,358.3,13438,2)
+122 ;;=^5006099
